Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 1,001–1,100 of 1,726
Yoshihara, T., Takiguchi, S., Kyuno, A., Tanaka, K., Kuba, S., Hashiguchi, S., Ito, Y., Hashimoto, T., Iwatsubo, T., Tsuyama, S., et al. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm239 · Cited by 30
Spoerri, L., Vella, L. J., Pham, C. L. L., Barnham, K. J., & Cappai, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355743 · Cited by 32
Itokazu, Y., & Yu, R. K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8634-8 · Cited by 27
Scherberich, J. E., Kellermeyer, M., Ried, C., & Hartinger, A. (2005) · PubMed · Cited by 42
Consideration of the ischaemic basis and treatment of Alzheimer's disease.
Pluta, R. M., Ułamek, M., & Jabłoński, M. (2010) · PubMed · Cited by 30
Padovani, A., Borroni, B., Colciaghi, F., Pastorino, L., Archetti, S., Cottini, E., Caimi, L., Cattabeni, F., & Luca, M. D. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00315-3 · Cited by 35
Inhibition of β-amyloid cytotoxicity by midkine
Yu, G. S. P., Hu, J., & Nakagawa, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00685-5 · Cited by 29
Liu, F. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00152-6 · Cited by 29
Kraus, M., Bienert, M., & Krause, E. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.901 · Cited by 30
Klunk, W. E., Xu, C., McClure, R. J., Panchalingam, K., Stanley, J. A., & Pettegrew, J. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010266.x · Cited by 33
“Although the exact mechanisms are not known, soluble A~ is constitutively produced through normal processing of ~PP (l-Iaass et al.. 1992; Seubert et al., 1992; Shoji et al., 1992).”
BackgroundSchmitt, T. L., Steiner, E., Klinger, P., Sztankay, A., & Grubeck‐Loebenstein, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.4.8636387 · Cited by 29
Chu, T., Tran, T., Yang, F., Beech, W., Cole, G. M., & Frautschy, S. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01161-2 · Cited by 29
Dillen, K., & Annaert, W. G. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)54005-7 · Cited by 33
Kisilevsky, R., Narindrasorasak, S., Tape, C., Tan, R., & Boudreau, L. (1994) · Amyloid · doi:10.3109/13506129409148449 · Cited by 29
Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?
Menéndez‐González, M., & Gasparovic, C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01036 · Cited by 29
Wang, Y., Wu, Q., Anand, B. G., Karthivashan, G., Phukan, G., Yang, J., Thinakaran, G., Westaway, D. A., & Kar, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12647 · Cited by 33
Haribabu, J., Ranade, D. S., Bhuvanesh, N. S. P., Kulkarni, P. P., & Karvembu, R. (2017) · ChemistrySelect · doi:10.1002/slct.201702390 · Cited by 29
Koudinova, N. V., Koudinov, A. R., & Yavin, E. (2000) · Neurochemical Research · doi:10.1023/a:1007511120099 · Cited by 30
Transforming growth factor β2 autocrinally mediates neuronal cell death induced by amyloid‐β
Hashimoto, Y., Nawa, M., Chiba, T., Aiso, S., Nishimoto, I., & Matsuoka, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20804 · Cited by 31
“Combined with the finding in earlier studies that nM levels of Abs were observed in cerebrospinal fluids in AD patients (Seubert et al., 1992; Shoji et al., 1992), it is reasonable that increased Ab42 upregulates expression of TGFb2 in AD patients.”
BackgroundMethodHoyer, A., Bardenheuer, H. J., Martin, E., & Plaschke, K. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0176-1 · Cited by 30
“Ab4 is normally formed in picomolar=nanomolar concentrations and is found in plasma and cerebrospinal fluid in secreted form (Haass et al., 1992; Seubert et al., 1992).”
BackgroundHajimohammadreza, I., Anderson, V., Cavanagh, J. B., Seville, M. P., Nolan, C. C., Anderton, B. H., & Leigh, P. N. (1994) · Brain Research · doi:10.1016/0006-8993(94)91853-8 · Cited by 29
Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques.
Prior, R., D’Urso, D., Frank, R. W., Prikulis, I., Cleven, S., Ihl, R., & Pavlaković, G. (1996) · Europe PMC (PubMed Central) · Cited by 29
Amyloid β proteins inhibit Cl−‐ATPase activity in cultured rat hippocampal neurons
Yagyu, K., Kitagawa, K., Irie, T., Wu, B., Zeng, X.-T., Hattori, N., & Inagaki, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00446.x · Cited by 28
“As the concentration of Abs in human cerebrospinal ¯uid is reportedly 2.5 ng/mL (625 pm, Seubert et al. 1992) to 5 nm (Nakamura et al. 1994), the concentration in early onset AD groups being higher than that in older normal groups, effects of nm concentrations of Abs are of physiological and/or…”
BackgroundInfluentialThe molecular pathogenesis of Alzheimer's disease: clinical prospects
Murphy, M. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92765-8 · Cited by 28
Commentary: Aβ N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology
Tekirian, T. L. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3209 · Cited by 31
“This increased production of AβN11x as a result of BACE expression is fascinating as this observation links cleavage of N-terminal Aβ generation from APP in AD brain to separate studies which support AβN11-x as a predominant isoform in amyloid [33], as a major species in media derived from mixed brain cell cultures [4…”
Plasma β-amyloid 1–42 reference values in cognitively normal subjects
Zecca, C., Tortelli, R., Panza, F., Arcuti, S., Piccininni, M., Capozzo, R., Barulli, M. R., Barone, R., Cardinali, R., Abbrescia, D. I., et al. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.06.006 · Cited by 31
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 31
“However, multi-step structured analysis strategies are required in order to reduce the influence of non-specific binders and improve the signal quality (Table 1) [76].”
BackgroundGiudice, E. D., Facchinetti, F., Nofrate, V., Boccaccio, P., Minelli, T. A., Dam, M., Leon, A., & Moschini, G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.057 · Cited by 29
Serem, W. K., Bett, C. K., Ngunjiri, J. N., & Garno, J. C. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20940 · Cited by 30
“The peptide Ab is a normal, soluble component of human plasma and cerebrospinal fluid (Pitschke et al., 1998; Seubert et al., 1992).”
BackgroundMonitoring the earliest amyloid-β oligomers via quantized photobleaching of dye-labeled peptides
Dukes, K. D., Rodenberg, C. F., & Lammi, R. K. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.07.011 · Cited by 29
Erythrocytes as Potential Link between Diabetes and Alzheimer’s Disease
Carelli‐Alinovi, C., & Misiti, F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00276 · Cited by 26
“, 1995) and blood (Seubert et al., 1992), where it interacts with red blood cells (RBC).”
Backgroundd’Uscio, L. V., He, T., Santhanam, A. V. R., & Katušić, Z. S. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17735418 · Cited by 33
“Hence, the presence of sAPPa and sAPPb in circulation suggests that APP and its cleavage products might play a role in normal human physiology.(16,37) In the present study, we found that endotheliumdependent relaxations to acetylcholine were impaired in basilar arteries derived from APP / mice while relaxations to DEA…”
BackgroundInfection‐induced endothelial amyloids impair memory
Balczon, R., Pittet, J., Wagener, B. M., Moser, S. A., Voth, S. B., Vorhees, C. V., Williams, M. T., Bridges, J. P., Alvarez, D. F., Koloteva, A., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900322r · Cited by 29
Inestrosa, N. C., Alarcón, R., Arriagada, J., Donoso, A., & Alvarez, J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90216-8 · Cited by 27
Smith, C. J., & Anderton, B. H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00977.x · Cited by 32
β-Amyloid and Cholinergic Neurons
Doležal, V., & Kašparová, J. (2003) · Neurochemical Research · doi:10.1023/a:1022865121743 · Cited by 30
White matter amyloid in Alzheimer's disease brain
Uchihara, T., Kondo, H., Akiyama, H., & Ikeda, K. (1995) · Acta Neuropathologica · doi:10.1007/bf00294459 · Cited by 28
Time-course of oxidation of lipids in human cerebrospinal fluidin vitro
Arlt, S., Finckh, B., Beisiegel†, U., & Kontush, A. (2000) · Free Radical Research · doi:10.1080/10715760000300111 · Cited by 27
Role of Apolipoprotein E in Alzheimer’s Disease
Zannis, V. I., Zanni, E. E., Makrides, S. C., Kardassis, D., & Aleshkov, S. B. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0133-0_13 · Cited by 27
Analytical Aspects of Molecular Alzheimer’s Disease Biomarkers
Andréasson, U., Vanmechelen, E., Shaw, L. M. J., Zetterberg, H., & Vanderstichele, H. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.44 · Cited by 30
Structural and mechanistic commonalities of amyloid-β and the prion protein
Dias, B. D. C., Jovanovic, K., Gonsalves, D., & Weiss, S. F. T. (2011) · Prion · doi:10.4161/pri.5.3.17025 · Cited by 31
“1).(22) Furthermore, as has been mentioned above, Aβ generation is a normal physiological process and Aβ levels in the cerebrospinal fluid and plasma of healthy individuals are in the 3–8 nM range(23) and 500 pM respectively.”
BackgroundPawlik, M., Sastre, M., Calero, M., Mathews, P. M., Schmidt, S. D., Nixon, R. A., & Levy, E. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:1-2:13 · Cited by 28
“Aβ has been reported to have heterogeneous carboxyl termini, with Aβ1–40 and Aβ1–42 being the major species produced (Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992).”
BackgroundLiu, Y., Sparatore, A., Soldato, P. D., & Bian, J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.023 · Cited by 29
“Amyloid-b peptide (Ab), normally secreted by neurons is a major constituent of senile plaques and a hallmark of AD, which can be found in low concentrations (about 0.1–1 nM) in cerebrospinal fluid (CSF) and plasma (Seubert et al., 1992).”
InfluentialProteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update
Portelius, E., Brinkmalm, G., Pannee, J., Zetterberg, H., Blennow, K., Dahlén, R., Brinkmalm, A., & Gobom, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1384697 · Cited by 28
Kinetics of Surface-Mediated Fibrillization of Amyloid-β (12–28) Peptides
Lin, Y., Li, C., & Fakhraai, Z. (2018) · Langmuir · doi:10.1021/acs.langmuir.7b02744 · Cited by 27
Effects of Aβ25–35on neurogenesis in the adult mouse subventricular zone and dentate gyrus
Li, X., & Zuo, P. (2005) · Neurological Research · doi:10.1179/016164105x35585 · Cited by 26
Acero, G., Manoutcharian, K., Vasilevko, V., Munguía, M. E., Govezensky, T., Coronas, G., Luz-Madrigal, A., Cribbs, D. H., & Gevorkian, G. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.003 · Cited by 29
“The main Aβ variants detected in the human brain are Aβ1–40 and Aβ1–42, however a significant proportion of AD brain Aβ consists also of N-terminal truncated/modified species (Mori et al., 1992; Seubert et al., 1992; Saido et al., 1995, 1996; Kuo et al., 1997; Tekirian et al., 1998; Russo et al., 2001; Miravalle et al…”
BackgroundPepeu, G., Giovannelli, L., Casamenti, F., Cali, C., & Bartolini, L. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)62111-1 · Cited by 30
Chapter 21. Alzheimer's Disease: Current Therapeutic Approaches
John, V., Lieberburg, I. M., & Thorsett, E. D. (1993) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60891-x · Cited by 26
Self-citationPanegyres, P. K. (1997) · Neuropeptides · doi:10.1016/s0143-4179(97)90000-7 · Cited by 30
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
Pawlowski, M., Meuth, S., & Duning, T. (2017) · Diagnostics · doi:10.3390/diagnostics7030042 · Cited by 25
“In parallel, novel and highly sensitive antibodies allowed the first detection of Aβ by enzyme-linked immunosorbant assays (ELISA) in biological fluids, including CSF and plasma [63].”
BackgroundThe Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer’s Disease
Cortés-Malagón, E. M., Ornelas, A. L., Olvera‐Gómez, I., & Bonilla‐Delgado, J. (2024) · Brain Sciences · doi:10.3390/brainsci14090950 · Cited by 28
RETRACTED: Matrine protects neuro-axon from CNS inflammation-induced injury
Kan, Q., Lv, P., Zhang, X., Xu, Y., Zhang, G., & Zhu, L. D. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.01.001 · Cited by 30
RetractedHierarchical ordering of amyloid fibrils on the mica surface
Zhou, X., Zhang, Y., Zhang, F., Pillai, S., Liu, J., Li, R., Dai, B., Li, B., & Zhang, Y. (2013) · Nanoscale · doi:10.1039/c3nr00886j · Cited by 25
Inflammation in Alzheimer’s disease
Heneka, M. T. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.005 · Cited by 34
Potential applications of SPR in early diagnosis and progression of Alzheimer's disease
Liu, L., Xia, N., & Wang, J. (2012) · RSC Advances · doi:10.1039/c2ra00667g · Cited by 29
Grimwood, S., Hogg, J. E., Jay, M. T., Lad, A. M., Lee, V. S., Murray, F., Peachey, J., Townend, T., Vithlani, M., Beher, D., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.016 · Cited by 25
Ghosh, C., & Dey, S. G. (2013) · Inorganic Chemistry · doi:10.1021/ic301865n · Cited by 27
New approaches to diagnose and treat alzheimer's disease
Galasko, D. R. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70075-6 · Cited by 29
Restraint stress induces β-amyloid precursor protein mRNA expression in the rat basolateral amygdala
Rosa, M. L. N. M., Guimarães, F. S., de Oliveira, R. M. W., Padovan, C. M., Pearson, R. C. A., & Bel, E. A. D. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.011 · Cited by 27
Schwarzman, A. L., Tsiper, M. V., Gregori, L. L., Goldgaber, D., Frackowiak, J., Mazur‐Kolecka, B., Taraskina, A. E., Пчелина, С. Н., & Vitek, M. P. (2005) · Amyloid · doi:10.1080/13506120500350762 · Cited by 36
Turgeon, V. L., Salman, N., & Houenou, L. J. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00300-5 · Cited by 29
Characterization of the acetylcholine-reducing effect of the amyloid-β peptide in mouse SN56 cells
Pedersen, W. A., & Blusztajn, J. K. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00913-0 · Cited by 26
Cheung, T. T., Ghiso, J. A., Shojif, M., Cai, X.-D., Golde, T. E., Gandy, S., Frangione, B., & Younkin, S. G. (1994) · Amyloid · doi:10.3109/13506129409148622 · Cited by 25
Greenberg, B. (1995) · Amyloid · doi:10.3109/13506129509036927 · Cited by 30
Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
Levy, E., Prelli, F., & Frangione, B. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s337 · Cited by 24
Probst, G. D., Bowers, S., Sealy, J. M., Stupi, B. P., Dressen, D. B., Jagodzinska, B. M., Aquino, J., Gailunas, A. F., Truong, A. P., Tso, L. S., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.070 · Cited by 25
Self-citationAlterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease
Salazar, A., Osse, A. M. L., Ortiz, A. A., Murtishaw, A. S., & Kinney, J. W. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.013 · Cited by 26
Butterfield, S. M., & Lashuel, H. A. (2010) · Angewandte Chemie · doi:10.1002/ange.200906670 · Cited by 24
Alzheimer disease is in part a thrombohemorrhagic disorder
Schmaier, A. H. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13277 · Cited by 24
The Golgi apparatus and the pathogenesis of Alzheimer's disease.
Canto, M. C. D. (1996) · Europe PMC (PubMed Central) · Cited by 28
Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease
Selkoe, D. J. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00016-5 · Cited by 31
Self-citationSchmitt, T. L., Steiner, E., Trieb, K., & Grubeck-Loebenstein, B. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3606 · Cited by 24
Strosznajder, J. B., Zambrzycka, A., Kacprzak, M. D., & Strosznajder, R. P. (1999) · Journal of Molecular Neuroscience · doi:10.1007/bf02736924 · Cited by 24
Increased amyloid production from aberrant beta-amyloid precursor proteins.
Zhong, Z., Quon, D. H., Higgins, L. S., Higaki, J. N., & Cordell, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32698-4 · Cited by 26
β‐Amyloid Precursor Protein Mismetabolism and Loss of Calcium Homeostasis in Alzheimer's Diseasea
Barger, S. W., Smith‐Swintosky, V. L., Rydel, R. E., & Mattson, M. P. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23045.x · Cited by 26
Molecular biology of brain aging and neurodegenerative disorders
Wısnıewskı, T., & Frangione, B. (1996) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1996-1132 · Cited by 27
“Studies in the last three years have documented the presence of a soluble AP-like peptide (SAP) in normal biological fluids at low concentrations (Haass et al. 1992, Seubert et al. 1992, Shoji et al. 1992, Busciglio et al. 1993).”
BackgroundImmunotherapy with β -Amyloid for Alzheimer's Disease: A New Frontier
Schenk, D., Seubert, P. A., & Ciccarelli, R. B. (2001) · DNA and Cell Biology · doi:10.1089/10445490152717532 · Cited by 24
“Finally, it has recently been suggested that passive administration of the monoclonal antibody 266 (Seubert et al. , 1992) acts as a “sink” to reduce CNS A b by capturing the peptide peripherally (DeMattos et al. , 2001).”
Self-citationFree Intracellular Calcium in Peripheral Cells in Alzheimer's Disease
Eckert, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80308-9 · Cited by 24
Li, L.-B., & Wang, Z. (2016) · PubMed · doi:10.14670/hh-11-737 · Cited by 24
“Aβ is derived from a transmembrane protein, the β-amyloid precursor protein (APP), by the action of two cleavage enzymes that are referred to as β- and γ-secretases (Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992).”
BackgroundCerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer’s disease
Zhang, L., Liang, X., Zhang, Z., & Luo, H. (2021) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545822300014 · Cited by 24
Hu, X., Meier, M., & Pruessner, J. C. (2023) · Brain and Behavior · doi:10.1002/brb3.2925 · Cited by 24
“The reason for the improved performance of Aβ42/Aβ40 ratio is still unclear, but it is hypothesized that Aβ40 can serve as an indicator of total Aβ and the ratio offsets the individual differences of total Aβ level in CSF (Lewczuk et al., 2015).”
BackgroundInfluentialdel Campo, M., & Teunissen, C. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131364 · Cited by 27
Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Alkadhi, K. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376307 · Cited by 23
“During normal cellular metabolism, neurons secrete low levels of soluble A peptides into cerebrospinal fluid and plasma [61, 62].”
Bora, R. P., & Prabhakar, R. S. (2009) · The Journal of Chemical Physics · doi:10.1063/1.3249609 · Cited by 26
Goch, W., & Bal, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170749 · Cited by 25
Go with the Flow—Microfluidics Approaches for Amyloid Research
Zilberzwige‐Tal, S., & Gazit, E. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201801007 · Cited by 33
Alzheimer's disease: Molecular genetics and transgenic animal models
Lannfelt, L., Folkesson, R., Mohammed, A. H. S., Winblad, B. G., Hellgren, D., Duff, K., & Hardy, J. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90137-f · Cited by 24
Rashid, U., & Ansari, F. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50002-7 · Cited by 29
Funke, S. A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/151645 · Cited by 24
“A variety Aβ oligomeric conformers, ranging from dimers to high-molecular-weight species, have been described in vitro and in vivo, being highly diverse with regard to structure and shape [7–9, 30–32].”
BackgroundAluminum-sensitive degradation of amyloid β-protein1–40 by murine and human intracellular enzymes
Banks, W. A., Maness, L. M., Banks, M. F., & Kastin, A. J. (1996) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(96)00084-0 · Cited by 23
The treatment of Alzheimer's disease
Allen, N. H. P., & Burns, A. S. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900108 · Cited by 26
Wen, G. Y., Wı́sniewski, H. M., Blöndal, H., Benedikz, E., Frey, H., Pirttilä, T., Rudelli, R. D., & Kim, K. S. (1994) · Acta Neuropathologica · doi:10.1007/bf00293394 · Cited by 23
“The presence of A~ in human cerebrospinal fluid [7, 15, 17 , 24] and the existence of non-fibrillar, soluble A[3 in cell-culture supernatant was recently reported [3, 6]. It is thought that non-fibrillar (preamyloid) deposits are an early step in A~ fibrillogenesis and development of some neuritic plaques.”
Pluta, R. M., Misicka, A., Januszewski, S., Barcikowska, M., & Lipkowski, A. W. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6837-0_76 · Cited by 23
Golabek, A. A., Kida, E., Walus, M., Perez, C., Wısnıewskı, T., & Soto, C. A. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76354-5 · Cited by 28
“ApoE is a major apolipoprotein in the brain and in CSF, and its expression is increased significantly after central and peripheral nerve injuries (Ignatius et al., 1986; Kida et al., 1995b).”
BackgroundPetersen, L. C., Bjørn, S. E., Norris, F., Norris, K. E., Sprecher, C. A., & Foster, D. C. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80115-0 · Cited by 23
Shepherd, C. E., Bowes, S., Parkinson, D., Cambray-Deakin, M. A., & Pearson, R. C. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00197-4 · Cited by 23
Facchinetti, F., Fasolato, C., DELGIUDICE, E., Burgo, A., Furegato, S., Fusco, M., Basso, E., Seraglia, R., D'Arrigo, A. M., & Leon, A.-S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.006 · Cited by 26
Singh, V. K., Cheng, J., & Leu, S.-J. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)91313-7 · Cited by 24
Strazdaitė, S., Roeters, S. J., Sakalauskas, A., Šneideris, T., Kirschner, J., Pedersen, K. B., Schiøtt, B., Jensen, F., Weidner, T., Smirnovas, V., et al. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c04882 · Cited by 22
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.